A Physiologically Based Pharmacokinetic Modelling of Sarilumab in Rheumatoid Arthritis Special Populations
Drug Targets and Therapeutics · 31.03.2026 · 5 (1) · 24-31
DOI: 10.58502/dtt.25.0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, erschienen am 31.03.2026. Verfasst von Thanh Thi Tran und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chungnam National University, Institute of Information & Communications Technology Planning Evaluation, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Chungnam National University
- Institute of Information & Communications Technology Planning Evaluation
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
- Korea Environmental Industry and Technology Institute
- Ministry of Environment
- Ministry of Health and Welfare
- Korea Institute of Toxicology
Zitieren
APA
Tran, T. T., Vu, N. T., Lee, S., Yun, H., & Chae, J. (2026). A Physiologically Based Pharmacokinetic Modelling of Sarilumab in Rheumatoid Arthritis Special Populations. Drug Targets and Therapeutics, 5(1), 24-31. https://doi.org/10.58502/dtt.25.0018
Vancouver
Tran TT, Vu NT, Lee S, Yun H, Chae J. A Physiologically Based Pharmacokinetic Modelling of Sarilumab in Rheumatoid Arthritis Special Populations. Drug Targets and Therapeutics. 2026;5(1):24-31. doi:10.58502/dtt.25.0018
BibTeX
@article{Tran2026,
author = {Tran, Thanh Thi and Vu, Ngoc-Anh Thi and Lee, Soyoung and Yun, Hwi-yeol and Chae, Jung-woo},
title = {A Physiologically Based Pharmacokinetic Modelling of Sarilumab in Rheumatoid Arthritis Special Populations},
journal = {Drug Targets and Therapeutics},
year = {2026},
volume = {5},
number = {1},
pages = {24--31},
doi = {10.58502/dtt.25.0018}
}
EUVIMED